
[Cancer Research 39, 162-169, January 1, 1979]
© 1979 American Association for Cancer Research
Correlation of Isozyme Patterns of S-Adenosylmethionine Synthetase with Fetal Stages and Pathological States of the Liver1
Ming C. Liau2,
Chen Fee Chang,
Luc Belanger3 and
A. Grenier
Department of Biochemistry, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77030 [M. C. L., C. F. C.]; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennesse 37232 [L. B.]; and Department of Human Genetics, University Hospital, Laval University, Quebec, Quebec, Canada G1V 4G2 [A. G.]
The liver is the most active organ engaged in S-adenosylmethionine metabolism. S-Adenosylmethionine synthetase isozymes (EC 2.5.1.6) were studied in normal, fetal, and pathological livers including hepatoma to correlate their activities with developmental stages and pathophysiological states of the liver. Three isozymes of S-adenosylmethionine synthetase, namely low, intermediate, and high-Km, have been identified from adult rat and human livers. The Km (methionine) are 3.6 µM, 23 µM, and 1.03 mM for the rat liver isozymes and 3.1 µM, 20 µM, and 0.65 mM for the human liver isozymes. The high-Km isozyme could be distinguished from other isozymes by its dependency on sulfhydryl reagents, activation by dimethyl sulfoxide, and chromatographic behaviors on Sepharose 6B and DEAE-cellulose columns. The activity of the low-Km isozyme, and to a lesser extent that of the intermediate-Km isozyme, was greatly enhanced in livers characteristic of rapid growth, such as in fetal, newborn, and regenerating livers. In contrast, the activity of the high-Km isozyme was undetectable in fetal livers and was greatly reduced during the growth phase of remnant liver following partial hepatectomy. Only the intermediate-Km isozyme was detectable in rat Novikoff hepatoma, indicating a unique metabolic feature associated with this tumor with respect to isozymes of S-adenosylmethionine synthetase. Such an aberration may have significant bearing on liver neoplasia. Livers of patients who died of hereditary tyrosinemia showed abnormal isozyme patterns of S-adenosylmethionine synthetase. The high-Km isozyme was either undetectable, thus resembling the fetal pattern, or present in a relatively low amount. It is suggested that abnormal development of S-adenosylmethionine synthetase isozymes may be partly responsible for abnormal methionine metabolism and hepatic dysfunctions often associated with these patients.
1 Supported by Grant G635 from The Robert A. Welch Foundation and Institutional Biomedical Research Support Grant RR5511-15.
2 To whom requests for reprints should be addressed.
3 Supported by a postdoctoral fellowship from the Medical Research Council of Canada.
Received 2/13/78.
Accepted 10/13/78.
This article has been cited by other articles:

|
 |

|
 |
 
H. Yang, Z.-Z. Huang, Z. Zeng, C. Chen, R. R. Selby, and S. C. Lu
Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer
Am J Physiol Gastrointest Liver Physiol,
February 1, 2001;
280(2):
G184 - G190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Lu, Z.-Z. Huang, H. Yang, J. M. Mato, M. A. Avila, and H. Tsukamoto
Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver
Am J Physiol Gastrointest Liver Physiol,
July 1, 2000;
279(1):
G178 - G185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. LeGros Jr., A.-B. Halim, A. M. Geller, and M. Kotb
Cloning, Expression, and Functional Characterization of the beta Regulatory Subunit of Human Methionine Adenosyltransferase (MAT II)
J. Biol. Chem.,
January 28, 2000;
275(4):
2359 - 2366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-B. Halim, L. LeGros, A. Geller, and M. Kotb
Expression and Functional Interaction of the Catalytic and Regulatory Subunits of Human Methionine Adenosyltransferase in Mammalian Cells
J. Biol. Chem.,
October 15, 1999;
274(42):
29720 - 29725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Z. Huang, Z. Mao, J. Cai, and S. C. Lu
Changes in methionine adenosyltransferase during liver regeneration in the rat
Am J Physiol Gastrointest Liver Physiol,
July 1, 1998;
275(1):
G14 - G21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H L. LeGros Jr., A. M. Geller, and M. Kotb
Differential Regulation of Methionine Adenosyltransferase in Superantigen and Mitogen Stimulated Human T Lymphocytes
J. Biol. Chem.,
June 20, 1997;
272(25):
16040 - 16047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. De La Rosa, J. Ostrowski, M. M. Hryniewicz, N. M. Kredich, M. Kotb, H. L. LeGros Jr., M. Valentine, and A. M. Geller
Chromosomal Localization and Catalytic Properties of the Recombinant alpha Subunit of Human Lymphocyte Methionine Adenosyltransferase
J. Biol. Chem.,
September 15, 1995;
270(37):
21860 - 21868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. LeGros, A.-B. Halim, M. E. Chamberlin, A. Geller, and M. Kotb
Regulation of the Human MAT2B Gene Encoding the Regulatory beta Subunit of Methionine Adenosyltransferase, MAT II
J. Biol. Chem.,
June 29, 2001;
276(27):
24918 - 24924.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1979 by the American Association for Cancer Research.